Previous Close | 1.6400 |
Open | 1.6900 |
Bid | 1.6600 x 400 |
Ask | 1.7300 x 600 |
Day's Range | 1.5500 - 1.7400 |
52 Week Range | 0.1710 - 5.4800 |
Volume | |
Avg. Volume | 832,451 |
Market Cap | 21.66M |
Beta (5Y Monthly) | 1.91 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -6.3400 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.00 |
Fort Lauderdale, Florida--(Newsfile Corp. - May 1, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader and pharmaceutical distributor, is applauding the reported historic move by the U.S. Drug Enforcement Administration ("DEA") to reclassify cannabis from its list of Schedule I drugs to Schedule III, following a recommendation from the federal Health and Human Services Department ("HHS"). "This expected rescheduling would come shortly after Germ
The recent price decline of 13% in Flora Growth Corp.'s ( NASDAQ:FLGC ) stock may have disappointed insiders who bought...
Acquisition capitalizes on TruHC's strategically built German cannabis platform, including:EU-GMP processing and production licenseGDP wholesale license for import / exportEU-GMP certified customizable modules with flexibility to incorporate various production / packaging processes and which enable license extension for future in country cultivation and supply to cannabis dispensariesNarcotics license with EU-GMP certified storageEU-GMP certified laboratory for instant cannabis analysisTransacti